BlueSpring Bio

BlueSpring Bio is a gene therapy startup developing treatments for disorders of the central nervous system. Its initial programs focus on rare diseases caused by single gene defects, including Pompe disease, NAGLU deficiency, and spinal cerebellar ataxia. The company also has an Alzheimer’s disease development program.